The average price target for 20/20 Biolabs, Inc. is 1.74. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1.83 ,the lowest forecast is $1.65. The average price target represents -2.38% Decrease from the current price of $1.78.